Clarithromycin resistance and 23S rRNA gene point mutations of Helicobacter pylori infection in children

Çağan-Appak Y, Gazi H, Ayhan S, Cengiz-Özyurt B, Kurutepe S, Kasırga E. Clarithromycin resistance and 23S rRNA gene point mutations of Helicobacter pylori infection in children. Turk J Pediatr 2016; 58: 371-376.This study aims to evaluate Helicobacter pylori with clarithromycin resistant genotypes in Manisa region, Turkey. Two hundred patients, who received diagnosis of Helicobacter pylori infection histopathologically, were included. The sex, age and endoscopy indications of the patients were recorded. Polymerase chain reaction method was applied to determine the clarithromycin resistance rate and resistance genotypes at the histologic sections prepared from gastric biopsies that had been embedded in paraffin after fixation by formalin. Helicobacter pylori resistance to clarithromycin was found in 19/200 (9.5%) patients. 10/19 (52.6%) of these clarithromycin-resistant patients had A2143G mutation and 9/19 (47.4%) had A2142G mutation. A2142C mutation on 23S rRNA gene was not detected for any of the patients. Clarithromycin can be used as a first step treatment in the eradication of Helicobacter pylori for the children in our region; if the treatment fails for some patients, clarithromycin resistance, especially A2143G and A2142G mutations should be considered.

___

1. Goodwin CS, Mendall MM, Northfield TC. Helicobacter pylori infection. Lancet 1997; 349: 265-269.

2. Helicobacter pylori in Peptic Ulcer Disease. NIH Consensus Statement 1994; 12: 1-23.

3. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789.

4. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997; 10: 720-741.

5. Ozen A, Ertem D, Pehlivanoglu E. Natural history and symptomatology of Helicobacter pylori in childhood and factors determining the epidemiology of infection. J Pediatr Gastroenterol Nutr 2006; 42: 398-404.

6. Malfertheiner P, Megraud F, O'Morain CA, et al. European Helicobacter Study Group. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut 2012; 61: 646-664.

7. Megraud F. H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004; 53: 1374-1384.

8. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-781.

9. Kalach N, Benhamou PH, Campeotto F, Bergeret M, Dupont C, Raymond J. Clarithromycin resistance and bacterial eradication of Helicobacter pylori in children. Antimicrob Agents Chemother 2001; 45: 2134-2135.

10. Toracchio S, Marzio L. Primary and secondary antibiotic resistance of Helibocater pylori strains isolated in central Italy during the years 1998-2002. Dig Liver Dis 2003; 35: 541-545.

11. Ahmad N, Zakaria WR, Mohamed R. Analysis of antibiotic susceptibility patterns of Helicobacter pylori isolates from Malaysia. Helicobacter 2011; 16: 47-51.

12. Talebi Bezmin Abadi A, Mobarez AM, Taghvaei T, Wolfram L. Antibiotic resistance of Helicobacter pylori in Mazandaran, North of Iran. Helicobacter 2010; 15: 505-509.

13. Ben Mansour K, Burucoa C, Zribi M, et al. Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study. Ann Clin Microbiol Antimicrob 2010; 9: 22.

14. Simsek H, Balaban YH, Gunes DD, Hascelik G, Ozarlan E, Tatar G. Alarming clarithromycin resistance of Helicobacter pylori in Turkish population. Helicobacter 2005; 10: 360-361.

15. Onder G, Aydin A, Akarca U, Tekin F, Ozutemiz O, Ilter T. High Helicobacter pylori resistance rate to clarithromycin in Turkey. J Clin Gastroenterol 2007; 41: 747-750.

16. Sezgin O, Aslan G, Altintaş E, Tezcan S, Serin MS, Emekdaş G. Detection of point mutations on 23S rRNA of Helicobacter pylori and resistance to clarithromycin with PCR-RFLP in gastric biopsy specimens in Mersin, Turkey. Turk J Gastroenterol 2008; 19: 163-167.

17. Ozçay F, Koçak N, Temizel IN, et al. Helicobacter pylori infection in Turkish children: comparison of diagnostic tests, evaluation of eradication rate, and changes in symptoms after eradication. Helicobacter 2004; 9: 242-248.

18. Erdur B, Ozturk Y, Gurbuz ED, Yilmaz O. Comparison of sequential and standard therapy for Helicobacter pylori eradication in children and investigation of clarithromycin resistance. J Pediatr Gastroenterol Nutr 2012; 55: 530-533.

19. Karabiber H, Selimoglu MA, Otlu B, Yildirim O, Ozer A. Virulence factors and antibiotic resistance in children with Helicobacter pylori gastritis. J Pediatr Gastroenterol Nutr 2014; 58: 608-612.

20. de Francesco V, Margiotta M, Zullo A, et al. Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan realtime polymerase chain reaction. Aliment Pharmacol Ther 2006; 23; 429-435.

21. Street ME, Caruana P, Caffarelli C,et al. Antibiotic resistance and antibiotic sensitivity-based treatment in Helicobacter pylori infection: advantages and outcome. Arch Dis Child 2001; 84: 419-422.

22. Egan BJ, Katicic M, O'Connor HJ, O'Morain CA. Treatment of Helicobacter pylori. Helicobacter 2007; 12: 31-37.

23. Vakil N. Helicobacter pylori treatment: a practical approach. Am J Gastroenterol 2006; 101: 497-499.

24. Debets-Ossenkopp YJ, Sparrius M, Kusters JG, Kolkman JJ, Vandenbroucke-Grauls CM. Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. FEMS Microbiol Lett 1996; 142: 37-42.

25. Feydt-Schmidt A, Rüssmann H, Lehn N, et al. Fluorescence in situ hybridization vs. epsilometer test for detection of clarithromycin-suspectible and clarithromycin-resistant Helicobacter pylori strains in gastric biopsies from children. Aliment Pharmacol Ther 2002;16: 2073-2079.

26. Oleastro M, Ménard A, Santos A, et al. Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori. J Clin Microbiol 2003; 41: 397- 402.

27. Soltermann A, Perren A, Schmid S, et al. Assessment of Helicobacter pylori clarithromycin resistance mutations in archival gastric biopsy samples. Swiss Med Wkly 2005; 135: 327-332.

28. Schmitt BH, Regner M, Mangold KA, Thomson RB Jr, Kaul KL. PCR detection of clarithromycin-susceptible and -resistant Helicobacter pylori from formalin-fixed, paraffin-embedded gastric biopsies. Mod Pathol 2013; 26: 1222-1227.

29. Francavilla R, Lionetti E, Castellaneta S, et al. Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. J Pediatr 2010; 157: 228-232.

30. De Francesco V, Zullo A, Ierardi E, et al. Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits. J Antimicrob Chemother 2010; 65: 327-332.

31. Trespalacios AA, Otero W, Caminos JE, et al. Phenotypic and genotypic analysis of clarithromycin-resistant Helicobacter pylori from Bogotá D.C., Colombia. J Microbiol 2013; 51: 448-452.

32. Abadi AT, Taghvaei T, Ghasemzadeh A, Mobarez AM. High frequency of A2143G mutation in clarithromycinresistant Helicobacter pylori isolates recovered from dyspeptic patients in Iran. Saudi J Gastroenterol 2011; 17: 396-399.
Turkish Journal of Pediatrics-Cover
  • ISSN: 0041-4301
  • Yayın Aralığı: Yılda 6 Sayı
  • Başlangıç: 1958
  • Yayıncı: Hacettepe Üniversitesi Çocuk Sağlığı Enstitüsü Müdürlüğü
Sayıdaki Diğer Makaleler

An unusual manifestation: Papillary thyroid carcinoma in a patient with ataxia-telengiectasia

GÜZİDE AKSU, ŞÜKRAN DARCAN, SAMİM ÖZEN, Damla GÖKŞEN, NESLİHAN KARACA, Ezgi ULUSOY, NECİL KÜTÜKÇÜLER, YEŞİM ERTAN

Intravesical catheter knotting: an unusual complication of suprapubic catheterization

MURAT YİĞİTER, Ahmet Bedii SALMAN

Multisystem langerhans cell histiocytosis with thymic involvement diagnosed with anterior mediastinal mass in a 2-month-old boy

Funda TEKKEŞİN, Arzu OKUR, Betül Emine DERİNKUYU, Nalan AKYÜREK, Aynur OĞUZ, Ceyda KARADENİZ, FARUK GÜÇLÜ PINARLI

The first childhood case with coexisting Hashimoto thyroiditis, vitiligo and autoimmune hepatitis

Şenay SAVAŞ-ERDEVE, Semra ÇETİNKAYA, Ferda ÖZBAY-HOŞNUT, Erdal KURNAZ, Melikşah KESKİN, Zehra AYCAN¹

Anti-cyclic citrullinated peptide antibodies are not frequently observed in children with type 1 diabetes mellitus: a single- center study

Melek YILDIZ, Özlem NALBANTOĞLU, Nilüfer ÇELİK, Figen İŞLETEN, Birsen TUĞLU, Behzat ÖZKAN, Korcan DEMİR, Hüseyin Anıl KORKMAZ

Idiopathic giant cell myocarditis in a newborn: case report

Barış AKDUMAN, Dilhan TÜRKKAN, Mustafa KARAPİRLİ, Hanife ALKAN-ALKURT, Doğuş ÖZDEMİR-KARA, Sultan PEHLİVAN

Efficacy of asthma education program on asthma control in children with uncontrolled asthma

Özkan KARAMAN, Şule ÇAĞLAYAN-SÖZMEN, Özden ANAL, Nevin UZUNER, Sakine IŞIK, Zeynep ARIKAN-AYYILDIZ

Surgical and clinical strategies in the management of thyroid medullary carcinoma in children with and without ret proto- oncogene mutations

Özlem BOYBEYİ-TÜRER, DOĞUŞ VURALLI KARAOĞLAN, İbrahim KARNAK, Nazlı GÖNÇ, Emel Şule YALÇIN, Diclehan ORHAN, Nurgün KANDEMİR, Feridun Cahit TANYEL

Kawasaki disease shock syndrome: a rare and severe complication of Kawasaki disease

Mustafa ÇAKAN, Hakan GEMİCİ, Nuray AKTAY AYAZ, GONCA KESKİNDEMİRCİ, Helen BORNAUN, Tarkan İKİZOĞLU, Alpay ÇELİKER

Oxygen therapy via high flow nasal cannula in pediatric intensive care unit

Arzu OTO, Seher ERDOĞAN, MEHMET BOŞNAK